Silexion Therapeutics Corp

Developing a local drug delivery platform to treat KRAS-driven cancers and solid tumors.

SLXN | US

Overview

Corporate Details

ISIN(s):: KYG1281K1141 (+1 more)
LEI:
Country:: United States of America
Address:: 12 ABBA HILLEL ROAD, 5250606 RAMAT GAN
Website:: https://www.moringaac.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Silexion Therapeutics Corp is a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for KRAS-driven cancers and other solid tumors, such as pancreatic cancer. The company's core technology is its proprietary LODER (Local Drug Eluter) drug delivery platform. This platform is designed to provide local and prolonged delivery of therapeutic agents directly within the tumor core, aiming to solve significant drug delivery challenges and improve outcomes for patients with hard-to-treat cancers. Silexion is also developing innovative RNA-based therapeutics and collaborates with industry partners to advance its clinical manufacturing and formulation development.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Silexion Therapeutics Corp filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Silexion Therapeutics Corp

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Silexion Therapeutics Corp via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
CELADON PHARMACEUTICALS PLC Vertically integrated pharma developing cannabis medicines for chronic pain.	United Kingdom	CEL
Celcuity Inc. Developing targeted PI3K/mTOR inhibitor therapies for breast and prostate solid tumors.	United States of America	CELC
Celemics, Inc. Develops custom NGS panels and bioinformatics for research and clinical diagnostics.	South Korea	331920
Cellbion Co., Ltd Develops & manufactures radiopharmaceuticals for cancer diagnosis and therapy.	South Korea	308430
CELL BIOTECH CO ., LTD A global biotech firm offering probiotic raw materials, OEM/ODM services, and consumer brands.	South Korea	049960
Celldex Therapeutics, Inc. Develops antibody-based therapies for severe inflammatory, allergic, and autoimmune diseases.	United States of America	CLDX
Cellectar Biosciences, Inc. Late-stage biopharma developing targeted cancer therapies with a proprietary PDC delivery platform.	United States of America	CLRB
Cellectis Develops 'off-the-shelf' CAR T-cell cancer immunotherapies using TALEN® gene-editing.	France	ALCLS
Cellectis S.A. Developing allogeneic CAR T-cell cancer immunotherapies using TALEN® gene-editing technology.	United States of America	CLLS
Cellid Co., Ltd. Biotech firm developing proprietary vaccine platforms for cancer and infectious diseases.	South Korea	299660